The rapid improvement and extensive application of cryo-EM has a potential to revolutionize pharmaceutical industry.
Our research has gained new mechanistic insights of important drug targets, critical multidrug transporters, and unexpected modes of action for small-molecule inhibitors.
Our ongoing work is to experiment and establish next-generation drug discovery pipelines, which will be structure data-driven and consist of technological advancements in computation biology and synthetic biology.
